This item requires a subscription to Annals of Internal Medicine.
Please note: Some PDFs are free 6 months after publication.
Cover
Figures
Brief Communications: Phase I Studies of Hypericin, the Active Compound in St. John's Wort, as an Antiretroviral Agent in HIV-Infected Adults: AIDS Clinical Trials Group Protocols 150 and 258
  • Roy M. Gulick,
  • Vincent McAuliffe,
  • Jeanne Holden-Wiltse,
  • Clyde Crumpacker,
  • Leonard Liebes,
  • Daniel S. Stein,
  • Patricia Meehan,
  • Sheila Hussey,
  • Janet Forcht,
  • Fred T. Valentine,
  • and for the AIDS Clinical Trials Group 150 and 258 Protocol Teams
Ann Intern Med March 16, 1999 130:510-514
To view this item, select one of the options below:

This Article

  1. Ann Intern Med March 16, 1999 vol. 130 no. 6 510-514
  1. AbstractFREE
  2. » Figures
  3. Full Text
  4. Full Text (PDF)

Rapid Responses

  1. Submit a response
  2. No responses published

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues